Latest Continuous Disclosure News

IperionX Limited has denied any undisclosed information following a sharp share price drop from $6.93 to $4.58, clarifying its accounting for U.S. government grants amid market volatility.

Dataworks Group Limited reveals ongoing strategic review with several parties engaged, highlighting the value of its self-exclusion technology and regulatory ties. While discussions remain preliminary, the company signals potential for significant strategic moves ahead.

ARC Funds Limited has been suspended from ASX trading due to a failure to maintain the minimum number of directors required by law, raising questions about its governance and future compliance.

Electro Optic Systems Holdings Limited (EOS) has responded to ASX concerns over insufficient details in its December 2025 announcement about a major US$80 million high energy laser contract, prompting a review and update of its continuous disclosure policy.

Manhattan Gold Limited has clarified recent share price and volume spikes, attributing them to strategic corporate communications and a fresh investor research report.

WA Kaolin Limited has responded to ASX queries clarifying that its Q2 FY2026 order book was a demand snapshot, not a sales forecast, and confirmed timely disclosure of a production shortfall linked to plant issues. The company also addressed regulatory notices, affirming no material impact on operations or securities value.

Oncosil Medical Ltd’s OSLOE securities have been suspended from trading by the ASX due to non-compliance with listing rules, raising questions about the company’s next steps.

Atlas Pearls Ltd has disclosed a significant 27% revenue decline and a net loss for the half year ended December 2025, attributing the results to weaker auction outcomes and one-off accounting impacts. The company affirms timely disclosure and compliance with ASX rules amid market sensitivity.

TZ Limited has responded to ASX queries over the deferral of a A$2.75 million debt repayment, asserting the delay was already well disclosed and unlikely to impact its share price materially.

Cyclopharm Limited has responded to ASX queries clarifying the material significance of its Technegas® contract with the US National Institutes of Health, while confirming robust progress in expanding its US footprint.

Classic Minerals has teamed up with Bain Global Resources to explore expanding its Goldbridge Processing Facility into a regional hub, aiming to boost gold production across Western Australia's Forrestania district.

BluGlass Limited has confirmed it is finalising a significant customer order following a sharp rise in its share price and trading volumes, with a formal announcement expected on 9 March 2026.